Abstract
Embryonic stem (ES) cells are clonal cell lines derived from the inner cell mass of the developing blastocyst that can proliferate extensively in vitro and are capable of adopting all the cell fates in a developing embryo. Clinical interest in the use of ES cells has been stimulated by studies showing that isolated human cells with ES properties from the inner cell mass1,2 or developing germ cells3 can provide a source of somatic precursors. Previous studies have defined in vitro conditions for promoting the development of specific somatic fates, specifically, hematopoietic, mesodermal, and neurectodermal4,5,6,7. In this study, we present a method for obtaining dopaminergic (DA) and serotonergic neurons in high yield from mouse ES cells in vitro. Furthermore, we demonstrate that the ES cells can be obtained in unlimited numbers and that these neuron types are generated efficiently. We generated CNS progenitor populations from ES cells, expanded these cells and promoted their differentation into dopaminergic and serotonergic neurons in the presence of mitogen and specific signaling molecules. The differentation and maturation of neuronal cells was completed after mitogen withdrawal from the growth medium. This experimental system provides a powerful tool for analyzing the molecular mechanisms controlling the functions of these neurons in vitro and in vivo, and potentially for understanding and treating neurodegenerative and psychiatric diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Thomson, J.A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145–1147 (1998).
Reubinoff, B. et al. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 18, 399–404 (2000).
Shamblott, M.J. et al. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc. Natl. Acad. Sci. USA 95, 13726–13731 (1998).
Klug, M.G. et al., Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J. Clin. Invest. 98, 216–24 (1996).
Keller, G. et al. Overexpression of HOX11 leads to the immortalization of embryonic precursors with both primitive and definitive hematopoietic potential. Blood 92, 877–87 (1998).
Wobus, A.M. & Boheler, K.R. Embryonic stem cells as developmental model in vitro. Cells Tiss. Org. 165, 129–30 (1999).
Bain, G. et al. Embryonic stem cells express neuronal properties in vitro. Dev. Biol. 168, 342–357 (1995).
Deacon, T. et al. Blastula-stage stem cells can differentiate into dopaminergic and serotonergic neurons after transplantation. Exp. Neurol. 149, 28–41 (1998).
Brustle, O. et al. Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science 285, 754–756 (1999).
Okabe, S. et al. Development of neuronal precursor cells and functional potmitotic neurons from embryonic stem cells in vitro. Mech. Dev. 59, 89–102 (1996).
Olanow, C.W., Kordower, J.H. & Freeman, T.B. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 19, 102–109 (1996).
Breier, A., et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc. Natl. Acad. Sci. USA 94, 2569–2574 (1997).
Gramm, L.F. Drug therapy: fluoxetine. N. Engl. J. Med. 331, 1354 (1994).
Volkow, N.D. et al. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386, 830–833 (1997).
Volkow, N.D. et al. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386, 827–830 (1997).
Simeone, A. Otx1 and Otx2 in the development and evolution of the mammalian brain. EMBO J. 17, 6790–6798 (1998).
Acampora, D. & Simeone, A. Understanding the roles of Otx1 and Otx2 in the control of brain morphogenesis. Trends Neurosci. 22, 116–122 (1999).
Stoykova, A. & Gruss, P. Roles of Pax genes in developing and adult brain as suggested by expression patterns. J. Neurosci. 14, 1395–1412 (1994).
Rowitch, D.H. & McMahon, A.P. Pax-2 expression in the murine neural plate precedes and encompasses the expression domains of Wnt-1 and En-1. Mech Dev. 52, 3–8 (1995).
Lendahl, U., Zimmerman, L.B. & McKay, R.D.G. CNS stem cells express a new class of intermediate filament proteins. Cell 60, 585–595 (1990).
Frederiksen, K. & McKay, R.D.G. Proliferation and differentiation of rat neuroephitelial precursor cells in vivo. J. Neurosci. 8, 1144–1151 (1988).
Johe, K. et al. Single factors direct the differentiation of stem cells from the fetal and adult nervous system. Genes Dev. 10, 3129–3140 (1996).
Vicario-Abejón, C. et al. Functions of basic-fibroblast growth factor and neurotrophins in the differentiation of hippocampal neurons. Neuron 15, 105–114 (1995).
Studer, L., Tabar, V. & McKay, R. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat. Neurosci. 1, 290–295 (1998).
Studer, L., Tabar, V. & McKay, R.D.G. Survival of expanded dopaminergic precursors is critical for clinical trials. Nat. Neurosci. 1, 537 (1998).
Ye, W. et al. FGF and SHH signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell 93, 755–766 (1998).
Branton, R.L., Love, R.M. & Clarke, D.J. cAMP included during cell suspension preparation improves survival of dopaminergic neurons in vitro. Neuroreport 9, 3223–3227 (1998).
Kalir, H.H. & Mytilineou, C. Ascorbic acid in mesencephalic cultures: effects on dopaminergic neuron development. J. Neurochem. 57, 458–464 (1991).
Brustle, O. et al. In vitro-generated neural precursors participate in mammalian brain development. Proc. Natl. Acad. Sci. USA 94, 14809–14814 (1997).
Spenger, C. et al. Fetal ventral mesencephalon of human and rat origin maintained in vitro and transplanted to 6-hydroxydopamine-lesioned rats gives rise to grafts rich in dopaminergic neurons. Exp. Brain Res. 112, 47–57 (1996).
Wagner, J. et al. Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes. Nat. Biotechnol. 17, 653–659 (1999).
Joyner, A.L. Engrailed, Wnt and Pax genes regulate midbrain–hindbrain development. Trends Genet. 12, 15–20 (1996).
Studer, L. et al. Noninvasive dopamine determination by reversed phase HPLC in the medium of free-floating roller tube cultures of rat fetal ventral mesencephalon: a tool to assess dopaminergic tissue prior to grafting. Brain Res. Bull. 41, 143–150 (1996).
Auerbach, J.M., Eiden, M.V. & McKay, R.D.G. Tranplanted CNS stem cells form functional synapses in vivo. Eur. J. Neurosci. 12, 1696–1704 (2000).
Acknowledgements
The R1 ES cell line was kindly provided by Dr. Heiner Westphal. The second ES cell line used E14.1 was a gift of Dr. Tom Doetschman. We would like to thank Dr. David Panchinsion for providing some of the PCR-primers and for critical discussions of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, SH., Lumelsky, N., Studer, L. et al. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 18, 675–679 (2000). https://doi.org/10.1038/76536
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/76536
This article is cited by
-
Development, wiring and function of dopamine neuron subtypes
Nature Reviews Neuroscience (2023)
-
Dental follicle cells show potential for treating Parkinson’s disease through dopaminergic-neuronogenic differentiation
Human Cell (2022)
-
The potential therapy with dental tissue-derived mesenchymal stem cells in Parkinson’s disease
Stem Cell Research & Therapy (2021)
-
Generation of functional dopaminergic neurons from human spermatogonial stem cells to rescue parkinsonian phenotypes
Stem Cell Research & Therapy (2019)
-
An Improved Method for Differentiating Mouse Embryonic Stem Cells into Cerebellar Purkinje Neurons
The Cerebellum (2019)